Type your tag names separated by a space and hit enter

Maternal-fetal transfer of melatonin in pregnant women near term.

Abstract

Our objective was to evaluate the maternal-fetal transfer of melatonin in pregnant women. Serum melatonin concentration was measured by high-performance liquid chromatography with electrochemical detection in a maternal vein and in the umbilical artery and umbilical vein at the time of birth. Blood samples were obtained from 12 women who had spontaneously delivered vaginally at night. A single oral dose of melatonin was administered to each of 33 patients who underwent a cesarean section, and, blood samples were taken at 1, 2, 3, or 4 hr after the administration of melatonin at delivery. Cesarean section was performed between 1300 and 1500 hr. The mean melatonin concentrations of melatonin in maternal peripheral venous blood and umbilical arterial and umbilical venous blood did not differ significantly, and positive correlations in the serum levels of melatonin were observed between the three sources of blood. The oral administration of 3 mg of melatonin to pregnant women led to marked increases in the serum levels of melatonin, with maximum levels observed 2 hr (21.84 +/- 2.09 ng/ml) after drug administration. Changes in serum levels of melatonin in the umbilical vein and artery resembled those found in the maternal vein. Serum melatonin concentrations did not differ significantly between the maternal vein and the umbilical veins. Serum levels of melatonin in the umbilical vein after the administration of melatonin were significantly and closely correlated with those in the maternal vein (r = 0.924, P < 0.001). These results suggest that, in humans, melatonin is transferred from the maternal to the fetal circulation both easily and rapidly. A potential for the therapeutic use of melatonin as an antioxidant exists in the patients with preeclampsia.

Links

  • Publisher Full Text
  • Authors+Show Affiliations

    ,

    Department of Obstetrics and Gynecology, Kochi Medical School, Japan.

    , , , ,

    Source

    Journal of pineal research 25:3 1998 Oct pg 129-34

    MeSH

    Adolescent
    Adult
    Biological Transport
    Chromatography, High Pressure Liquid
    Female
    Fetal Blood
    Gestational Age
    Humans
    Maternal-Fetal Exchange
    Melatonin
    Placenta
    Pregnancy
    Umbilical Arteries
    Umbilical Veins

    Pub Type(s)

    Journal Article

    Language

    eng

    PubMed ID

    9745980

    Citation

    Okatani, Y, et al. "Maternal-fetal Transfer of Melatonin in Pregnant Women Near Term." Journal of Pineal Research, vol. 25, no. 3, 1998, pp. 129-34.
    Okatani Y, Okamoto K, Hayashi K, et al. Maternal-fetal transfer of melatonin in pregnant women near term. J Pineal Res. 1998;25(3):129-34.
    Okatani, Y., Okamoto, K., Hayashi, K., Wakatsuki, A., Tamura, S., & Sagara, Y. (1998). Maternal-fetal transfer of melatonin in pregnant women near term. Journal of Pineal Research, 25(3), pp. 129-34.
    Okatani Y, et al. Maternal-fetal Transfer of Melatonin in Pregnant Women Near Term. J Pineal Res. 1998;25(3):129-34. PubMed PMID: 9745980.
    * Article titles in AMA citation format should be in sentence-case
    TY - JOUR T1 - Maternal-fetal transfer of melatonin in pregnant women near term. AU - Okatani,Y, AU - Okamoto,K, AU - Hayashi,K, AU - Wakatsuki,A, AU - Tamura,S, AU - Sagara,Y, PY - 1998/9/24/pubmed PY - 1998/9/24/medline PY - 1998/9/24/entrez SP - 129 EP - 34 JF - Journal of pineal research JO - J. Pineal Res. VL - 25 IS - 3 N2 - Our objective was to evaluate the maternal-fetal transfer of melatonin in pregnant women. Serum melatonin concentration was measured by high-performance liquid chromatography with electrochemical detection in a maternal vein and in the umbilical artery and umbilical vein at the time of birth. Blood samples were obtained from 12 women who had spontaneously delivered vaginally at night. A single oral dose of melatonin was administered to each of 33 patients who underwent a cesarean section, and, blood samples were taken at 1, 2, 3, or 4 hr after the administration of melatonin at delivery. Cesarean section was performed between 1300 and 1500 hr. The mean melatonin concentrations of melatonin in maternal peripheral venous blood and umbilical arterial and umbilical venous blood did not differ significantly, and positive correlations in the serum levels of melatonin were observed between the three sources of blood. The oral administration of 3 mg of melatonin to pregnant women led to marked increases in the serum levels of melatonin, with maximum levels observed 2 hr (21.84 +/- 2.09 ng/ml) after drug administration. Changes in serum levels of melatonin in the umbilical vein and artery resembled those found in the maternal vein. Serum melatonin concentrations did not differ significantly between the maternal vein and the umbilical veins. Serum levels of melatonin in the umbilical vein after the administration of melatonin were significantly and closely correlated with those in the maternal vein (r = 0.924, P < 0.001). These results suggest that, in humans, melatonin is transferred from the maternal to the fetal circulation both easily and rapidly. A potential for the therapeutic use of melatonin as an antioxidant exists in the patients with preeclampsia. SN - 0742-3098 UR - https://www.unboundmedicine.com/medline/citation/9745980/Maternal_fetal_transfer_of_melatonin_in_pregnant_women_near_term_ L2 - https://onlinelibrary.wiley.com/resolve/openurl?genre=article&amp;sid=nlm:pubmed&amp;issn=0742-3098&amp;date=1998&amp;volume=25&amp;issue=3&amp;spage=129 DB - PRIME DP - Unbound Medicine ER -